Influenza A viruses are highly infectious pathogens that constantly circulate in many animal hosts including humans, birds, pigs, horses and dogs. Infections with influenza viruses result in protective immunity mediated by antibodies against the viral surface glycoproteins hemagglutinin (HA) and neuraminidase (NA). However, human and some avian influenza viruses have continuously undergone antigenic evolution to evade pre-existing host immunity, a phenomenon known as antigenic drift (accumulation of point mutations in HA and NA antigens). Antigenic drift explains the occurrence of repeated seasonal influenza epidemics in humans. In order to determine the virus' attack rate, cross-sectional seroprevalence studies are necessary. Typically, these seroprevalence studies of influenza viruses rely on HI (Hemagglutinin Inhibition assay) or MN (microneutralization test) to measure antibody titers in serum samples; these tests can have low sensitivity and they normally offer binary results (past infection, or not). Here, we conducted a seroprevalance study of influenza virus A/H1N1 and A/H3N2 in Ho Chi Minh City population between 2010 and 2015 using a novel protein microarray to measure the continuous-scale antibody titers against these subtypes in 5000 serum samples. Our platform is high-throughput, reproducible and can provide more informative antibody titers than previous assays. We also perform whole-genome sequencing of 190 influenza strains to investigate the antigenic changes of these subtypes over the study period. Tracking the antigenic changes of the viruses couple with a measurement of antibiotic response against these viruses in a population is an ideal data set to understand the evolution and immuno-epidemiology of these important pathogens and to provide timely and accurate data for the selection of vaccine strains.
